Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I bought today
3 2018 leaps 35$ strike
news like this and no one is here postng anything
$XON recent news/filings
bearish 36.67
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$XON DD Notes ~ http://www.ddnotesmaker.com/XON
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/XON/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/XON/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=XON+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=XON+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=XON+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/XON/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/XON/news - http://finance.yahoo.com/q/h?s=XON+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/XON/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/XON/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/XON/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/XON/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/XON/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/XON/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/XON/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/XON/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=XON+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/XON
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/XON/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/XON
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/XON/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/XON/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/XON/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/XON/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/XON/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/XON/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/XON/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=XON&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=XON
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/XON/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=XON+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=XON+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=XON
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=XON
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=XON+XONh+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/XON/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=XON+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/XON.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=XON
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/XON/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/XON/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/XON/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/XON/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/XON
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/XON
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/XON:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=XON
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=XON
StockTwits (stocktwits.com): http://stocktwits.com/symbol/XON
$XON DD Notes ~ http://www.ddnotesmaker.com/XON
Down 11% today.. Almost time to jump on this for a quick ride up again!
41 dollars a share someone is willing to pay 200 million , expect to buy share under 40 dollars a share .
Big drop coming soon as Central Bank upholds China's currency devaluation. Commodities selloff likely hits US markets hard tomorrow
horrible earnings coming in, compared to what this company is worth on paper , usually 10 times earnings ,PE ,you were told .
up over 20% last 30 days roflmao almost a 3 bagger YTD
What goes up hard comes down hard , looks like no profits, in 5 to 10 years maybe .
This stock has been on fire!!!!!
XON on CNBC today, up 15%+ in 2 days, looks like a beast of a LT play.
It has been in this price channel for a few months now. A traded familiar with their pattern would have done really well.
BAC-ML healthcare conference Tuesday May 12th.
RJ Kirk will be presenting at 8:40am pst.
Food is a small part of the overall picture.
Takes years to grow those apple trees before any profit is seen plus PE is very high .
How patience pays in biotechnology
http://www.biohealthinvestor.com/
Look at these prices of these leaders in Big cap bio just between 2 to 4 years ago. If you could afford to buy just say 500 to 1k shares you would be close to a millionaire. The only thing more important than having the funds to have bought them was to have the patience to hold through all the bumps in the road.
Are the previous holders of MEDS which acquired XON through buyout satisfied with their agreement?
Abstracts on Sleeping Beauty Released
http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=e8b9bf9f-ac96-4582-a814-8a4feb688c9a&cKey=e1449847-2960-4d43-8a62-864f0b16cf73&mKey=19573a54-ae8f-4e00-9c23-bd6d62268424
http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=2dc87f5d-bfb3-4e4d-8f48-e2567464386a&cKey=f586761e-ab49-4c79-b4b3-84b36b5bb555&mKey=19573a54-ae8f-4e00-9c23-bd6d62268424
30% of XON has been shorted ,shorts will hire and bash bash bash till they can get in low , it is a sad state when a short can sells shares and cover in 10 days .
XON to meet with JPM in May
http://www.theflyonthewall.com/permalinks/entry.php/XONid2015845/XON-Intrexon-management-to-meet-with-JPMorgan
Updated Griffin report - post earnings
Food and Healthcare Likely to Carry 2015
Several collaborators will advance human therapeutics into
clinical trials this year. Overall, Intrexon figures that about 10
products developed with its assistance will be in testing. Ziopharm
alone will likely account for at least half of them and two other
companies, Fibrocell Science and Synthetic Biologics, will have
one each. Another therapy that was mentioned was developed as
part of the Sun Pharma joint venture in ophthalmology. Recently
acquired ActoGenix has two clinical-stage programs involving
genetically modified bacteria for oral mucositis and inflammatory
bowel disease, which will probably be partnered soon.
A pending acquisition will expand Intrexon’s presence in
the food sector… The Company has agreed to pay $41 million
for Okanagan Specialty Fruits, including $10 million in cash and
the remainder in XON stock. The deal, which should close by
June, will bring two approved, non-browning apple varieties into
the product line and add three similar genetically modified fruit
programs to the R&D pipeline. Note that we do not expect
revenues from Okanagan until 2017.
…while Trans Ova should drive revenues this year. This
subsidiary, which was acquired last August, will likely generate
close to $100 million in revenue from its dairy and cattle
embryo sales and in vitro fertilization services. Demand, which
is seasonally strongest in the June quarter, is growing at a rapid
pace.
Intrexon closed 2014 on a pleasant note. Fourth-quarter
revenues benefited from $15.1 million in sales and service
revenues from Trans Ova in its first full quarter with the
Company. The other major contributor was $13 million in
collaboration revenues. Operating expenses were generally in
line with expectations. The profit margin on product and service
revenues, which were generated largely by Trans Ova, amounted
to 29% during the seasonally weak December interim. R&D costs
increased 41%, to $59 million, while selling and administrative
expenses jumped 61%, to $64 million, due largely to acquisitions.
Overall, the operating loss increased modestly from year-toyear,
to $19 million. More than offsetting that was unrealized
appreciation in stocks of the Company’s collaborators, which
resulted in a $0.19-a-share profit in the quarter.
We are maintaining our BUY recommendation on Intrexon
shares and our $65 price target.
http://www.griffinsecurities.com/viewpdf.php?docid=959
Tom,
CorMedix, Inc. (CRMD) -NYSE MKT
6.16 Up 0.66(12.00%) 4:02PM EST
After Hours : 6.19 Up 0.03 (0.49%) 7:03PM EST
Yes Ziop down.......profit taking?
ZIOPHARM Oncology, Inc. (ZIOP) -NasdaqCM
13.34 Up 0.85(6.81%) 4:00PM EST
After Hours : 12.94 Down 0.40 (3.00%) 7:48PM EST
Tell me how both CRMD and ZIOP are walked down red after hours?
I went from being up 20k+ to being down 1300 for the day.
I hope CRMD opens at 5.40 tomorrow like the last trade for 1K.
I know ya can't reply here. Look for your thoughts on IV
Let it consolidate for a minute. Needs to churn in 40's so it doesn't have a heavy bleed.
For every flipper grabbing quick profits stronger hands are buying. Is up almost 100% in a month.
What about ADXS and MDGN?
The 3 Amigo's are rolling along
XON ZIOP CRMD
CRMD news out this am, looks good.
I wasn't obv serious, but this will be over a $50.00 stock tomorrow and this news hasn't even been seen by some of the big plays...we could see $55.00 easy by EOW.
Should be fun tomorrow
Apples
Not so fast Apples... i am sure we will see some profit taking at the end of the run which would be a good entry point, i agree this could be a 100.00 stock at some point but not in a month, XON has some great potential in many different area's.
POSITIVE RESULTS FOR CANCER STOCK, THIS COULD SEE $100.00 IN A MONTH, LOW O/S
This is huge, Shorts are gonna cover soon...that alone will push this to $55.00 maybe sooner then I originally though...if your not in yet, this is a must own stock at 48.00
are they covering today??? up 6.35 KABOOM I just opened a position yesterday morning, ZIOP & CRMD are my 2 biggest holdings. i am paitently waiting for CRMD to get taken out so i can flip the funds right into XON
which will be a long term hold for me. I hate when that happenes!!!!
At what price does anyone think the shorts will finally cover ??
They must be in a world of hurt just about now....
...I wonder how much higher a short squeeze would push up the price??
XON running I'm in at 33.09
Looking for 53.09
Should be early next week
Apples
Intrexon Announces Fourth Quarter and Full Year 2014 Financial Results
http://finance.yahoo.com/news/intrexon-announces-fourth-quarter-full-210500595.html
"Looking ahead, we are very excited about our near term prospects and have much higher goals for 2015. In Health, we expect to see new major alliances formed, while we believe that our existing ECC partners will be in the clinic with up to ten novel therapeutic candidates. In Food, we anticipate continued growth of our base business with projected product and service revenues exceeding $100M," said CEO Randal Kirk of the company's prospects in 2015.
your welcome. check it out especially if you trade real biotech stocks. plenty of solid LT investors sharing critical DD. I find it really helpful along with doing my own DD.
Investors Villiage.
Investors community with boards on certain stocks like here. Lots of info on both XON and ZIOP posted. Much more than here.
May I ask what is "IV"?
Yeah, cowbunga, Bill Miller yikes! That's awesome. Bill Miller is an excellent trader. Did you see in the interview how they talked about Miller's timing of Amazon and why he went all in after the 3rd quarter earnings conference? Absolutely awesome market timing and he did it because of how the word "productivity" was used twice. The CNBC article referred to Intrexon as being the health care stock of the decade! Whoa. Source: This could be the stock of the decade: Bill Miller
The only thing I don't like about Intrexon is that the EPS forecast is going down even though the revenue is rocketing upward. But that's definitely something that is fixable and can be turned around.
Followers
|
48
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
412
|
Created
|
08/24/13
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |